Schubert & CO Abbott Laboratories Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $2,421 - $2,850	-25 Reduced 12.69%	172 $17,000
Q4 2022 Jan 31, 2023	SELL	$95.06 - $111.52 $3,707 - $4,349	-39 Reduced 16.53%	197 $21,000
Q3 2022 Oct 21, 2022	BUY	$96.76 - $112.03 $4,547 - $5,265	47 Added 24.87%	236 $23,000
Q2 2022 Aug 01, 2022	BUY	$102.07 - $123.37 $6,838 - $8,265	67 Added 54.92%	189 $21,000
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $8,551 - $10,428	75 Added 159.57%	122 $14,000
Q4 2021 Jan 28, 2022	BUY	$115.53 - $141.46 $5,429 - $6,648	47 New	47 $7,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.